Investigating insulin resistance in non-diabetic patients with acute coronary syndrome
Official title: Effects of Insulin Resistance in Non-diabetic Acute Coronary Syndrome Patients by the Homeostasis Model Assessment Index (HOMA2-IR)
Run by University of Medicine and Pharmacy at Ho Chi Minh City · NCT06163768 · Data updated 2026-11-12
This study is testing how insulin resistance affects people without diabetes who are having a heart problem to see if it can help prevent future health issues.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 1 (estimated) |
| Sponsor | University of Medicine and Pharmacy at Ho Chi Minh City Academic / other |
| Locations | 1 site (Ho Chi Minh City, Five) |
| Status | Recruiting |
| Started | December 31, 2023 |
| Main results expected | October 31, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | December 11, 2023 |
| Trial ID | NCT06163768 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 years old diagnosed with acute coronary syndrome who do not have diabetes.
✕Probably not a fit
Patients with a history of diabetes or those under 18 years old may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study examines the effects of insulin resistance in patients experiencing acute coronary syndrome who do not have diabetes. By utilizing the homeostasis model assessment index (HOMA2-IR), the research aims to enhance understanding of insulin resistance and its long-term implications, such as the risk of developing type 2 diabetes. The goal is to provide healthcare professionals with insights that could lead to more effective monitoring and treatment strategies, ultimately preventing diabetes and cardiovascular events.
Why it matters
Potential benefit: If successful, this study could lead to improved monitoring and treatment strategies for patients at risk of diabetes and cardiovascular issues.
How similar studies have gone: While the specific approach may be novel, studies on insulin resistance and its implications in cardiovascular health have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Control group The researcher collected samples from healthy people over 18 years old who came for a health check and were concluded to have good health at the Health Examination Department of University of Medicine and Pharmacy Hospital, Ho Chi Minh City. Not falling within the exclusion criteria and agreeing to participate in the study were included in the study. * Researchers -All patients diagnosed with Acute coronary syndrome who were over 18 years old, met the inclusion criteria and did not have exclusion criteria, and agreed to participate in the study were included in the study. Exclusion Criteria: * Control group * Patients \< 18 years old. * History of heart disease or stroke * Exclude diabetic subjects * Exclude subjects at high risk of insulin resistance * Researchers * Have diabetes or have previously been diagnosed with diabetes. * Patients \< 18 years old. * The patient does not participate in follow-up examinations and does not follow up treatment at the medical facility. * The patient died before reaching the hospital. * Patients with severe medical diseases: cirrhosis, cancer, obstructive pulmonary disease chronic obstructive pulmonary disease, chronic heart failure, severe kidney failure.
Where it's running
-
Medical and Pharmaceutical University Hospital
Ho Chi Minh City, Five, Vietnam Recruiting
Study contacts
- Study coordinator: Nguyen Ngoc Minh Thu
- Email: nnmthu.ncs.khys.hoasinh23@ump.edu.vn
- Phone: +84907484296
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
Prenatal Exercise to See How Cardio or Strength Training Affects Blood Sugar
This study tests whether different types and amounts of exercise during pregnancy can improve blood sugar control in women with gestational diabetes.
-
Alpelisib Challenge Test to measure insulin secretory capacity
Researchers will test a new approach to measure how much insulin the body can produce in people at various weights and with or without insulin resistance, using alpelisib around a meal test.
-
Inositol and Metformin with Mediterranean or Low-Carb Diets in Women with PCOS
This trial tests whether adding inositol, metformin, or folic acid to either a Mediterranean or a low-carbohydrate diet helps women with PCOS and insulin resistance lose weight and improve metabolic markers.
-
Inulin Prebiotic for Perimenopausal Women with Overweight or Obesity
This study tests whether 2 weeks of inulin can affect gut and vaginal microbes, heart health, and muscle health in perimenopausal women who are overweight or obese, using a crossover design.
-
Kodo Millet Porridge and Gut Health in Overweight and Obese Adults
This study tests whether daily intake of Kodo millet porridge for 12 weeks can improve gut bacteria and metabolic health in adults who are overweight or obese.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.